What they were paid
CAPRICOR THERAPEUTICS Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $50,000 | $0 | $234,340 | $0 | $284,340 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: CAPRICOR THERAPEUTICS, INC. DEF 14A filed April 10, 2026, accession 0001104659-26-042070, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025CAPRICOR THERAPEUTICS pays directors a $40,000 cash retainer and $250,000 in Stock Options.
Committees
FY2025 · as the proxy prints themNominating/Governance
The rest of the CAPRICOR THERAPEUTICS board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| David B. Musket | Independent Director | $380,601 |
| Frank Litvack, M.D | Chair of the Board | $735,350 |
| George W. Dunbar Jr., M.B.A | Independent Director | $325,595 |
| Karimah Es Sabar | Independent Director | $299,967 |
| Linda Marbán, Ph.D | Director | $0 |
| Michael Kelliher | Independent Director | $289,340 |
| Philip Gotwals, Ph.D | Independent Director | $301,842 |
The full CAPRICOR THERAPEUTICS compensation record
free company briefThis page is one director within CAPRICOR THERAPEUTICS's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat